pirinixic acid has been researched along with Diabetes Mellitus in 6 studies
pirinixic acid: structure
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "(-)DRF 2725 (6) is a phenoxazine analogue of phenyl propanoic acid." | 1.31 | (-)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activity. ( Bajji, AC; Chakrabarti, R; Juluri, S; Kalchar, S; Lohray, BB; Lohray, VB; Mamidi, NV; Misra, P; Padakanti, S; Poondra, RR; Rajagopalan, R; Vikramadithyan, RK, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Willson, TM | 1 |
| Brown, PJ | 1 |
| Sternbach, DD | 1 |
| Henke, BR | 1 |
| Lohray, BB | 1 |
| Lohray, VB | 1 |
| Bajji, AC | 1 |
| Kalchar, S | 1 |
| Poondra, RR | 1 |
| Padakanti, S | 1 |
| Chakrabarti, R | 1 |
| Vikramadithyan, RK | 1 |
| Misra, P | 1 |
| Juluri, S | 1 |
| Mamidi, NV | 1 |
| Rajagopalan, R | 1 |
| Pingali, H | 1 |
| Jain, M | 1 |
| Shah, S | 1 |
| Makadia, P | 1 |
| Zaware, P | 1 |
| Goel, A | 1 |
| Patel, M | 1 |
| Giri, S | 1 |
| Patel, H | 1 |
| Patel, P | 1 |
| Larter, CZ | 1 |
| Yeh, MM | 1 |
| Van Rooyen, DM | 1 |
| Brooling, J | 1 |
| Ghatora, K | 1 |
| Farrell, GC | 1 |
| Edvardsson, U | 1 |
| von Löwenhielm, HB | 1 |
| Panfilov, O | 1 |
| Nyström, AC | 1 |
| Nilsson, F | 1 |
| Dahllöf, B | 1 |
| Wang, Y | 1 |
| Botolin, D | 1 |
| Xu, J | 1 |
| Christian, B | 1 |
| Mitchell, E | 1 |
| Jayaprakasam, B | 1 |
| Nair, MG | 1 |
| Nair, M | 1 |
| Peters, JM | 2 |
| Busik, JV | 1 |
| Busik, J | 1 |
| Olson, LK | 1 |
| Jump, DB | 1 |
1 review available for pirinixic acid and Diabetes Mellitus
| Article | Year |
|---|---|
The PPARs: from orphan receptors to drug discovery.
Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligand | 2000 |
5 other studies available for pirinixic acid and Diabetes Mellitus
| Article | Year |
|---|---|
(-)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activity.
Topics: Animals; Biological Availability; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Hyperlip | 2001 |
Design and synthesis of novel oxazole containing 1,3-dioxane-2-carboxylic acid derivatives as PPAR alpha/gamma dual agonists.
Topics: Animals; Carboxylic Acids; Diabetes Mellitus; Drug Design; Hypoglycemic Agents; Mice; Mice, Inbred N | 2008 |
Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Topics: Adipose Tissue; Animals; Blotting, Western; Chemokine CCL2; Diabetes Mellitus; Disease Models, Anima | 2012 |
Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator-activated receptor activators.
Topics: Amino Acids; Animals; Carbohydrate Metabolism; Diabetes Mellitus; Electrophoresis, Gel, Two-Dimensio | 2003 |
Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.
Topics: Acetyltransferases; Adult; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Dia | 2006 |